[11C]dihydrotetrabenazine Positron Emission Tomography in Manganese-Exposed Workers.


Journal

Journal of occupational and environmental medicine
ISSN: 1536-5948
Titre abrégé: J Occup Environ Med
Pays: United States
ID NLM: 9504688

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 31 5 2020
medline: 7 8 2021
entrez: 31 5 2020
Statut: ppublish

Résumé

To understand the neurotoxic effects of manganese (Mn) exposure on monoaminergic function, utilizing [C]dihydrotetrabenazine (DTBZ) positron emission tomography (PET) to measure vesicular monoamine transporter 2 (VMAT2). Basal ganglia and thalamic DTBZ binding potentials (BPND) were calculated on 56 PETs from 41 Mn-exposed workers. Associations between cumulative Mn exposure, regional BPND, and parkinsonism were examined by mixed linear regression. Thalamic DTBZ BPND was inversely associated with exposure in workers with less than 3 mg Mn/m-yrs, but subsequently remained stable. Pallidal DTBZ binding increased in workers with less than 2 mg Mn/m-yrs of exposure, but decreased thereafter. Thalamic DTBZ binding was inversely associated with parkinsonism (P = 0.003). Mn-dose-dependent associations with thalamic and pallidal DTBZ binding indicate direct effects on monoaminergic VMAT2. Thalamic DTBZ binding was also associated with parkinsonism, suggesting potential as an early biomarker of Mn neurotoxicity.

Identifiants

pubmed: 32472844
doi: 10.1097/JOM.0000000000001915
pmc: PMC7786890
mid: NIHMS1647767
pii: 00043764-202010000-00003
doi:

Substances chimiques

Carbon Radioisotopes 0
Carbon-11 0
dihydrotetrabenazine 3466-75-9
Manganese 42Z2K6ZL8P
Tetrabenazine Z9O08YRN8O

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

788-794

Subventions

Organisme : NIEHS NIH HHS
ID : K24 ES017765
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES025991
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES026187
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES029524
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES026891
Pays : United States
Organisme : NIEHS NIH HHS
ID : K23 ES021444
Pays : United States
Organisme : NIEHS NIH HHS
ID : P42 ES004696
Pays : United States
Organisme : NIEHS NIH HHS
ID : R21 ES026084
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES025792
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES021488
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES013743
Pays : United States

Références

Eur J Neurol. 2015 May;22(5):845-52, e59-60
pubmed: 25690304
PLoS One. 2012;7(11):e49483
pubmed: 23185343
J Occup Environ Hyg. 2009 Jun;6(6):324-31
pubmed: 19288335
J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):844-51
pubmed: 12810765
PLoS One. 2014 Apr 09;9(4):e93900
pubmed: 24718592
Ann Neurol. 2011 May;69(5):803-10
pubmed: 21246604
J Cereb Blood Flow Metab. 2006 Sep;26(9):1198-212
pubmed: 16421508
Ind Health. 2007 Jun;45(3):497-500
pubmed: 17634700
Ann Neurol. 2000 Mar;47(3):345-52
pubmed: 10716254
Neurotoxicology. 2016 Sep;56:262-268
pubmed: 27293182
Mov Disord. 2001 Sep;16(5):838-48
pubmed: 11746613
Ann Occup Hyg. 2011 Jan;55(1):113-25
pubmed: 20870928
Neurotoxicology. 2018 Jan;64:43-49
pubmed: 28694016
Front Neuroendocrinol. 1998 Jul;19(3):187-231
pubmed: 9665836
J Neurol Sci. 2015;353(1-2):102-6
pubmed: 25936253
Neuroimage. 2011 Jun 1;56(3):1463-8
pubmed: 21396455
Neurology. 1996 Sep;47(3):718-26
pubmed: 8797470
Neurobiol Dis. 2019 Apr;124:176-182
pubmed: 30471418
Neurology. 2017 Jan 24;88(4):344-351
pubmed: 28031394
Neurotoxicology. 2012 Oct;33(5):1356-61
pubmed: 22975422
Mov Disord. 2002 May;17(3):568-75
pubmed: 12112209
J Cereb Blood Flow Metab. 2002 Feb;22(2):232-9
pubmed: 11823721
Acta Neurol Scand. 2010 Apr;121(4):237-43
pubmed: 20028341
Exp Neurol. 2017 Dec;298(Pt B):148-161
pubmed: 28987461
J Cereb Blood Flow Metab. 1996 Sep;16(5):834-40
pubmed: 8784228
Am J Ind Med. 2020 Jan;63(1):36-43
pubmed: 31647574
Neurotoxicology. 2018 Jan;64:30-42
pubmed: 28873337
Appl Radiat Isot. 1993 Dec;44(12):1487-9
pubmed: 7903060
Neurology. 2018 Sep 11;91(11):e1022-e1030
pubmed: 30097475
JAMA Neurol. 2014 Jun;71(6):758-66
pubmed: 24756323
Br J Ind Med. 1955 Jan;12(1):21-35
pubmed: 14351643
Brain. 2005 Dec;128(Pt 12):2777-85
pubmed: 16081470
Neurotoxicology. 2009 Jul;30(4):487-96
pubmed: 19465050
Neuroimage. 2012 Aug 15;62(2):774-81
pubmed: 22248573

Auteurs

Susan R Criswell (SR)

Department of Neurology (Dr Criswell, Dr Nielsen, Mr Warden, Dr Perlmutter, Mr Lenox-Krug, Dr Racette); Department of Radiology (Dr Perlmutter, Dr Moerlein); Department of Neuroscience (Dr Perlmutter); Program in Physical Therapy (Dr Perlmutter); Program in Occupational Therapy (Dr Perlmutter); Department of Biochemistry and Molecular Biophysics (Dr Moerlein), Washington University School of Medicine, St. Louis, Missouri ; Department of Environmental and Occupational Health Sciences (Dr Sheppard); Department of Biostatistics (Dr Sheppard), School of Public Health, University of Washington, Seattle, Washington; Department of Family Medicine and Public Health (Dr Checkoway); Department of Neurosciences (Dr Checkoway), School of Medicine, University of California, San Diego, La Jolla, California; Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Parktown, South Africa (Dr Racette).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH